×
No information is available for this page. · Learn why
For use in patients age 18 and older. ○ Documentation of CSCC, and that all of the following clinical scenarios are met:.
LIBTAYO is the FIRST AND ONLY treatment indicated for patients with locally advanced basal cell carcinoma (laBCC) previously treated with a hedgehog pathway ...